Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 0.52 MYR
Change Today +0.02 / 4.00%
Volume 5.5M
As of 4:58 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

tmc life sciences bhd (TMCL) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/9/15 - 0.75
52 Week Low
12/4/14 - 0.44
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for TMC LIFE SCIENCES BHD (TMCL)

Related News

No related news articles were found.

tmc life sciences bhd (TMCL) Related Businessweek News

No Related Businessweek News Found

tmc life sciences bhd (TMCL) Details

TMC Life Sciences Berhad, an investment holding company, primarily operates a multi-disciplinary tertiary care center and fertility center in Malaysia. The company’s tertiary care center provides healthcare services in various medical/surgical specialties and subspecialties, including anaesthesiology, obstetrics and gynaecology, ophthalmology, cardiology, dermatology, endocrinology, gastroenterology, fertility, hepatology, internal medicine, nephrology, paediatrics, psychiatry, radiology and interventional radiology, respiratory medicine, and urology, as well as breast and endocrine, cancer, cardiothoracic, colorectal, ENT, head and neck laser, general and minimally invasive, hepatobiliary, neuro, hand and micro, bariatric, oral and maxillofacial, orthopaedic, plastic and reconstructive, vascular and endovascular, and upper gastrointestinal surgeries. Its fertility center provides a range of fertility treatments for couples. The company also operates a women’s clinic; provides consultancy, laboratory, and embryology services; and offers gynaecological and fertility problem management services. In addition, it is involved in developing, marketing, and managing healthcare programs; and marketing and promoting healthcare products; and research and development, and property investment activities. TMC Life Sciences Berhad was founded in 1994 and is headquartered in Petaling Jaya, Malaysia. TMC Life Sciences Berhad operates as a subsidiary of Sasteria Pte. Ltd.

Founded in 1994

tmc life sciences bhd (TMCL) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

tmc life sciences bhd (TMCL) Key Developments

TMC Life Sciences Appoints Wong Yu Chee as Chief Financial Officer

TMC Life Sciences has appointed Wong Yu Chee as Chief Financial Officer. The effective date is August 03, 2015.

TMC Life Sciences Berhad Proposes Final Dividend for the Year Ended May 31, 2015

TMC Life Sciences Berhad announced that subject to the approval of the shareholders at the ensuing Annual General Meeting, the Board recommended a single tier final dividend of 1.4% for the financial year ended 31 May 2015 compared to 3% a year ago. The net amount payable is MYR 2.4 million.

TMC Life Sciences Berhad Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended May 31, 2015

TMC Life Sciences Berhad reported unaudited consolidated earnings results for the fourth quarter and full year ended May 31, 2015. For the quarter, revenue was MYR 28,501,000 against MYR 23,752,000 a year ago. Profit from operations was MYR 3,179,000 against MYR 4,605,000 a year ago. Interest income was MYR 1,713,000 against MYR 216,000 a year ago. Profit before tax was MYR 2,637,000 against MYR 2,803,000 a year ago. Profit after taxation was MYR 3,982,000 against MYR 2,681,000 a year ago. Profit attributable to owners of the parent was MYR 3,982,000 or 0.40 sen per diluted share against MYR 2,681,000 or 0.22 sen per diluted share a year ago. Increased revenue contributed by higher patient load catered for by increased bed capacity and additional consultants recruited. Lower profit before taxation for the current quarter was mainly due to one-off corporate exercise expenses of MYR 1.5 million. For the full year, revenue was MYR 103,185,000 against MYR 86,494,000 a year ago. The growth was contributed by additional bed capacity and more variety of services offered coupled with continuing marketing activities. Profit from operations was MYR 13,311,000 against MYR 13,956,000 a year ago. Interest income was MYR 3,653,000 against MYR 781,000 a year ago. Profit before tax was MYR 8,598,000 against MYR 6,740,000 a year ago. Profit after taxation was MYR 9,923,000 against MYR 6,457,000 a year ago. Profit attributable to owners of the parent was MYR 9,923,000 or 1.01 sen per diluted share against MYR 6,457,000 or 0.54 sen per diluted share a year ago. Net cash flows from operating activities were MYR 14,681,000 against MYR 11,706,000 a year ago. Acquisition of property plant and equipment was MYR 15,670,000 against MYR 3,274,000 a year ago. Net assets per share as at May 31, 2015 were MYR 0.31 against MYR 0.17 a year ago.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TMCL:MK 0.52 MYR +0.02

TMCL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TMCL.
View Industry Companies

Industry Analysis


Industry Average

Valuation TMCL Industry Range
Price/Earnings 45.0x
Price/Sales 4.4x
Price/Book 1.5x
Price/Cash Flow 43.3x
TEV/Sales 5.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TMC LIFE SCIENCES BHD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at